Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces inflammation and pain in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movalis (meloxicam) acts on inflammatory pathways to relieve pain and swelling in several musculoskeletal disorders.

Osteoarthritis: reduces joint pain and improves mobility. Rheumatoid arthritis: diminishes synovial inflammation and joint damage. Ankylosing spondylitis: alleviates spinal stiffness and pain. Acute pain: provides rapid analgesia for short‑term musculoskeletal discomfort.

Common Side Effects: - Nausea - Abdominal pain - Diarrhea - Headache

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Renal impairment or failure - Cardiovascular events such as myocardial infarction or stroke

Precautions should be taken to minimise risks associated with meloxicam therapy.

Assess renal function: adjust use in patients with impaired kidneys. Monitor hepatic enzymes: check liver function periodically. Evaluate cardiovascular risk: use cautiously in patients with heart disease. Avoid in known NSAID hypersensitivity: discontinue if allergic reaction occurs. Store at ambient temperature: keep in original pack, protect from moisture.

Meloxicam may interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated serum lithium levels. - ACE inhibitors or ARBs: possible reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and renal status. - SSRIs: increased risk of gastrointestinal bleeding.